Today's Date: June 1, 2023
Alzheimer's Association to Host Rallies in All 50 States to Make New Treatments for Alzheimer's Accessible   •   WEBTOON and Atlantic Records’ Hayley Kiyoko, Ava Max, and MAY-A Partner for “Love Stories,” a New Webcomic Ant   •   Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign   •   EoS Fitness Debuts New Gym in Henderson   •   Ecolomondo Concludes an Amending Agreement With Export Development Canada (EDC)   •   Hexaware's New Initiative: Championing Women's Return to Tech Careers with StrongHer Up Program   •   Amazon Expands Disaster Relief Hub to 2.4 Million Items for Donation as Hurricane Season Begins   •   NEW SOCIAL-FIRST DATING APP "ARCHER" LAUNCHES FOR GAY, BISEXUAL, AND QUEER MEN   •   Climate Change-Influenced Hurricane Season Could Threaten an Estimated 33 Million Homes According to CoreLogic   •   Copper Mountain Mining Publishes 2022 ESG Report   •   Hess Celebrates the Mini Toy Truck's 25th Silver Anniversary   •   Chambers USA 2023 Recognizes Dorsey Lawyers and Practices   •   Visible Wireless Partners with Benny Drama, The Old Gays for "No Straight Answers," the New Cross-Generational Game Show Celebra   •   BofA Report Finds 64% of Women Want Menopause-Specific Benefits, Yet Only 14% Believe Their Employer Recognizes the Need for The   •   Women For Economic Leadership and Development Appoints Kate Visconti to National Advisory Council   •   Submissions Now Open for $1 Million USD Seeding The Future Global Food System Challenge   •   Energy Recovery Inc. Announces Expanded U Series Product Line   •   OcuTerra Appoints Bill Steinkrauss as Chief Financial Officer   •   Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expe   •   The Max Foundation to Launch Treatment Access for Advanced Breast Cancer in Nine Countries Across Africa, Latin America, and Sou
Bookmark and Share Expands Disease Model Platform with Thousands of Additional Models from Top CROs

SAN DIEGO , March 20 /Businesswire/ -, the premier R&D marketplace for the biopharmaceutical industry, announced today that it has partnered with leading contract research organizations (CROs), including Crown Bioscience, Imagen Therapeutics and Experimental Pharmacology & Oncology Berlin-Buch (EPO) to boost the number of disease models currently available on its Disease Model Finder (DMF) to over 8,000, making it one of the world’s largest, if not largest, database for proprietary cancer models. The DMF helps medical researchers in the field of oncology identify the most appropriate models for their preclinical drug development projects.

“With the relationship that has with many disease model suppliers, we can aggregate data across suppliers, enabling researchers to make quantitative comparisons between disease models very quickly and efficiently,” stated Javier Pineda, PhD, Data Scientist at “In addition to rapid model comparisons across suppliers, the Disease Model Finder allows for automated purchasing through the marketplace, so that once a researcher finds the model they need, they can purchase the model or request services immediately.”

The Disease Model Finder uses several machine learning algorithms, such as clustering algorithms and dimensionality reduction algorithms, to process and aggregate the data from large, molecular, sequencing-based datasets from multiple suppliers. These algorithms also enable researchers to visualize high-dimensionality datasets in 2-D for direct, visual model comparisons, as well as conduct differential gene expression analysis for models of interest. In combination with the multifaceted filter functionality, this allows researchers to find and source appropriate models for their research much more efficiently.

“’s Disease Model Finder (DMF) allows researchers to accelerate their drug discovery projects by providing a centralized, curated dataset of models from leading CROs, including Crown Bioscience,” said Jeff Buchanan, Senior Director, Business Development at Crown Bioscience. “The DMF enables rapid model identification and decision making in a matter of minutes that previously would have taken weeks, and as a leader in preclinical drug discovery, Crown Bioscience is delighted to provide data for this valuable resource.”

Since its launch in the spring of 2021, the Disease Model Finder has added thousands of new disease models—including organoids, cell-derived xenografts (CDX), syngeneic models, immuno-oncology models and patient-derived cell lines—with more being added monthly.

“Adding Imagen’s patient-derived cell (PDC) model catalogue and our model characterization data to the Disease Model Finder will enable oncology drug developers to make more informed decisions about their programs,” said Jonathan Engler, Executive Chair and Acting CEO at Imagen Therapeutics. “Oncology drug attrition rates are still higher than other diseases and implementing PDCs – as advanced patient-derived preclinical models – at an earlier stage in drug development can significantly improve success rates, reduce costs, and ultimately lead to patient benefits.”

To begin browsing and purchasing oncology models, visit

About's mission is to empower and connect scientists worldwide. The company's digital research platform combines a custom-built, cloud native technology stack with white-glove customer and scientific support to enable scientists to run more innovative experiments in less time and at lower cost. leverages internally developed machine learning models to provide actionable insights that improve operational efficiency and effective research management. connects the world's top pharmaceutical companies, biotechnology companies and the US National Institutes of Health (NIH) to the world's largest network of scientific suppliers.

Visit to learn more.

Join on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram

STORY TAGS: Health Technology, Data Management, Technology, Pharmaceutical, Oncology, General Health, Genetics, Artificial Intelligence, Clinical Trials, Biotechnology, Science, Software, Networks, Internet, Research, Health, Product/Service, California, Europe, United States, North America,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News